All analyses
5 min read

Last updated:

Vitamin B12: the deficiency signs the studies really confirm

Between anemia, neurological disorders and fatigue, vitamin B12 deficiency covers very different pictures. Here is what clinical trials establish about its screening, its symptoms and the forms of supplementation that work.

10 studies citedsee the sources

Benjamin Sant

Co-founder of the School of Longevity

Assessment consultation, structured collection of information
Assessment consultation, structured collection of information

Vitamin B12 deficiency affects precise, identifiable populations

The available literature does not concern an undifferentiated general population. The clinical trials cited here involve well defined groups: children with nutritional macrocytic anemia in India, infants in Nepal during maternal pregnancy, 18-month-old toddlers in high-poverty areas of China, children with severe acute malnutrition, diabetic patients with peripheral neuropathy and low serum levels, older people followed for the prevention of cognitive decline.

This heterogeneity of the studied populations calls for cautious reading. A result obtained in a deficient child in a context of malnutrition does not automatically transpose to a Western adult on a vegan diet, even if the biological mechanism of deficiency shares common points. The practitioner must place the client in one of these risk categories before interpreting a number.

Populations at risk documented by the trials reviewed include children in situations of undernutrition, pregnant women in a context of nutritional deficiency, older people, and diabetic patients with neuropathy. For a healthy adult population without a dietary or digestive risk factor, none of the sources provided allows establishing a prevalence or a systematic screening protocol.

Macrocytic anemia remains the best established biological sign

The trial by Tandon et al., conducted in children with nutritional macrocytic anemia, compares parenteral and oral administration of vitamin B12 in a randomized controlled trial. This work confirms that macrocytic anemia constitutes the reference biological picture for objectifying a severe deficiency, independently of the route of administration chosen to correct it.

Singh et al., in a randomized trial comparing intranasal, intramuscular and intravenous routes in patients with B12 deficiency anemia, confirm that hematological recovery is the central indicator followed in these protocols. These data concern only the correction of an already established and biologically confirmed deficiency, not the early detection of a subclinical deficit.

Pathak et al. study the effect of B12 supplementation on hematological and anthropometric parameters in children with severe acute malnutrition, aged 1 to 60 months, managed in a nutritional rehabilitation center. This work extends the anemic sign to a context of combined deficiency, where vitamin B12 acts as one factor among others in height and weight recovery.

Neurological symptoms require a context of confirmed deficiency

Mansour et al. tested two oral doses of vitamin B12, 1,000 and 2,000 micrograms, in diabetic patients with peripheral neuropathy and a low serum B12 level. The trial measures precise neuropathic outcomes in a population where deficiency is documented by blood assay before the intervention. It is one of the rare sources in this corpus to link a concrete neurological symptom, neuropathy, to a measured B12 status.

This association must not be generalized to paresthesia or sensory disorders without prior assay. The trial concerns only diabetic patients already deficient in B12, not peripheral neuropathy of undetermined cause. Attributing diffuse neurological symptoms to B12 deficiency without supporting biomarkers goes beyond what this study allows asserting.

None of the sources provided documents an established link between B12 deficiency and symptoms such as isolated fatigue, mood disorders or paresthesia in the absence of an abnormal blood assay. The practitioner who hears these complaints must refer for a biological assay before any conclusion, and for medical advice if clear neurological signs appear, in particular walking or deep sensation disorders.

The effect on cognition remains uncertain in older people

Wang et al., in a systematic review and meta-analysis on B vitamins and the prevention of cognitive decline and incident dementia, and Ford et al., in a meta-analysis on B vitamin supplementation and cognitive function in older people, are the two most robust synthesis works available on this ground.

These two meta-analyses do not allow asserting that vitamin B12 supplementation, alone or combined with other B vitamins, prevents cognitive decline or dementia in an older person who is not deficient. The effect reported in the synthesized literature remains inconsistent according to the populations and protocols included.

Savic-Hartwig et al. show that a micronutrient supplement modifies homocysteine levels in older subjects, independently of their baseline B vitamin status. This result shifts the question: lowering homocysteine does not guarantee a measurable cognitive benefit. Homocysteine is an intermediate marker, not a clinical endpoint in itself. The article on preventing cognitive decline details the results achieved by trials and their limits.

Pregnancy and early childhood are a documented field of intervention

Chandyo et al. conducted a community-based double-blind placebo-controlled randomized trial in Nepal, evaluating the effect of vitamin B12 supplementation during pregnancy on infant growth and development. This trial, published in the Lancet, concerns a population where maternal B12 deficiency is frequent and documented.

Sheng et al. conducted a cluster randomized controlled trial on a dietary intervention targeting vitamin B12 status and cognitive level of 18-month-old toddlers, in high-poverty areas of China. This work links biological status and early cognitive development in a context of identified nutritional risk.

These two trials confirm that B12 supplementation has demonstrated value in contexts of documented maternal or infant deficiency, in areas of nutritional risk. They do not allow extrapolating a benefit of systematic supplementation in pregnant women or children in a population without an identified dietary risk factor.

The route of administration does not change the efficacy of correction

The trial by Singh et al. directly compares intranasal, intramuscular and intravenous routes for hematological recovery in B12 deficiency anemia. This work questions a widespread practice, systematic intramuscular injection, by comparing it with less invasive alternatives in patients with confirmed anemia.

The trial by Tandon et al. compares parenteral and oral routes in children, in the context of nutritional macrocytic anemia. The practical conclusion of these works converges: in a context of deficiency confirmed by assay, the oral route or alternatives to intramuscular injection achieve comparable hematological recovery in the populations studied.

Mansour et al. provide a dose element for the oral route, comparing 1,000 and 2,000 micrograms in neuropathic diabetic patients with low B12. The choice of route and dose must be built from the precise clinical context, the type of deficiency and the population, not from a prescribing habit transposed without verification.

Sources

  1. 1.Wang Z, et al. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis. Nutr Rev. 2022.
  2. 2.Ford AH, et al. Effect of Vitamin B Supplementation on Cognitive Function in the Elderly: A Systematic Review and Meta-Analysis. Drugs Aging. 2019.
  3. 3.Savic-Hartwig M, et al. A micronutrient supplement modulates homocysteine levels regardless of vitamin B biostatus in elderly subjects. Int J Vitam Nutr Res. 2024.
  4. 4.Tandon R, et al. Parenteral vs Oral Vitamin B12 in Children With Nutritional Macrocytic Anemia: A Randomized Controlled Trial. Indian Pediatr. 2022.
  5. 5.Singh SK, et al. Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial. Am J Hematol. 2026.
  6. 6.Chandyo RK, et al. The effect of vitamin B12 supplementation during pregnancy on infant growth and development in Nepal: a community-based, double-blind, randomised, placebo-controlled trial. Lancet. 2023.
  7. 7.Sheng X, et al. Effects of dietary intervention on vitamin B(12) status and cognitive level of 18-month-old toddlers in high-poverty areas: a cluster-randomized controlled trial. BMC Pediatr. 2019.
  8. 8.Pathak BK, et al. Effect of Vitamin B12 Supplementation on Hematological and Athropometric Parameters in Children With Severe Acute Malnutrition, Aged 1 to 60 Months in Nutritional Rehabilitation Center (RCT). Clin Pediatr (Phila). 2026.
  9. 9.Spahn DR, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet. 2019.
  10. 10.Mansour A, et al. Efficacy of Oral Vitamin B-12 at 1000 μg Compared with 2000 μg on Neuropathic Outcomes in Patients with Diabetic Peripheral Neuropathy and Low Serum Vitamin B-12: a Randomized Clinical Trial. J Nutr. 2026.

Reading studies is one thing, turning them into a plan is another

The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.

See the certification

11 modules, €2,200. Enrol

Benjamin Sant

Co-founder of the School of Longevity

Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.

This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.